TNF and rheumatoid arthritis: CD86 (B7-2) is identified as a strong modulator of TJ, SJ and DAS28 in the network analysis of TNF-α blocker treated patients and should represent a particular TNF-α independent mechanism that is active in RA patients (Figure 6).